Literature DB >> 23427382

Analysis on clinically drug-used law for lung-intestine related diseases.

Luan Gao1, Jian Wang, Fenggang Li, Sihua Gao, Yong Deng.   

Abstract

OBJECTIVE: To analyze the application laws of clinical drugs by descriptive statistical method with the clinical literatures guided by "lung being connected with large intestine" used as the object.
METHODS: Retrieve publicly published clinical literatures about "lung being connected with large intestine" in recent 30 years, establish the database of clinical literature, and study on the clinically drug-used laws by descriptive statistical analytic method.
RESULTS: The common high frequent drugs used for the lung-intestine related diseases were Gualou (Ructus Trichsanthis), Dahuang (Radix et Rhizoma), Kuxingren (Semen Armeniacae Amarum), Gancao (Radix Glycyrrhizae), Houpu (Cortex Magnoliae Officinalis), Zhishi (Fructus Aurantii Immaturus). For the different clinical syndrome types, in the commonly used drugs there were different characteristics, reflecting the principle of TCM syndrome differentiation treatment.
CONCLUSION: The common high frequent drugs used for the lung-intestine related diseases are Gualou (Fructus Trichsanthis), Dahuang (Radix et Rhizoma), Kuxingren (Semen Armeniacae Amarum), Gancao (Radix Glycyrrhizae), Houpu (Cortex Magnoliae Officinalis), Zhishi (Fructus Aurantii Immaturus), which are commonly-used drugs for the lung-intestine related diseases, with differences for different syndrome types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23427382     DOI: 10.1016/s0254-6272(13)60064-3

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  5 in total

1.  Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation.

Authors:  Dahae Lim; Youngwoo Cho; Woogyeong Kim; Sehee Jeong; Young Pyo Jang; Jinju Kim
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-02

2.  More Active Intestinal Immunity Developed by Obese Mice Than Non-Obese Mice After Challenged by Escherichia coli.

Authors:  Dongjie Cai; Bin Tian; Shuang Liang; Yao Cen; Jing Fang; Xiaoping Ma; Zhijun Zhong; Zhihua Ren; Liuhong Shen; Liping Gou; Ya Wang; Zhicai Zuo
Journal:  Front Vet Sci       Date:  2022-06-03

Review 3.  Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases.

Authors:  Hui Wang; Jing-Shi Liu; Shao-Hua Peng; Xi-Yun Deng; De-Mao Zhu; Sara Javidiparsijani; Gui-Rong Wang; Dai-Qiang Li; Long-Xuan Li; Yi-Chun Wang; Jun-Ming Luo
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

4.  Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat.

Authors:  Yu-Xiang Fei; Bo Zhao; Qi-Yang Yin; Yan-Ying Qiu; Guang-Hui Ren; Bo-Wen Wang; Ye-Fang Wang; Wei-Rong Fang; Yun-Man Li
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

5.  Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Lijing Yan; Lijin Yu; Linlin Zhao; Dongsheng Wang; Dilan Qin; Haiwei Fan; Ling Cheng; Musen Qiu; Xiao Chen; Lu Zhou; Juan Qiu; Jiamei Yao; Wenbo Wang; Xinjian Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-06       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.